HAPILTO
Live / Applied — Third extension granted (statement of use) (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 17 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98754628
- Mark type
- Stylized text
- Filed
- 17 Sept 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2026 — SOU EXTENSION 3 GRANTED
- 11 Sept 2026 — SOU EXTENSION 3 FILED
- 11 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2026 — SOU EXTENSION 2 GRANTED
- 11 Mar 2026 — SOU EXTENSION 2 FILED
- 11 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jul 2025 — SOU EXTENSION 1 GRANTED
- 01 Jul 2025 — SOU EXTENSION 1 FILED
- 01 Jul 2025 — SOU TEAS EXTENSION RECEIVED